The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin-Reference-Cited by-同舟云学术

The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin

Published:2016-03-15 Issue:3 Volume:11 Page:e0151543
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kashi Zahra,Mahrooz Abdolkarim,Kianmehr Anvarsadat,Alizadeh Ahad

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes;JB Buse;Diabetes Obes Metab,2004

2. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials;J Costa;BMJ,2006

3. Drugs for cardiovascular risk reduction in the diabetic patient;DSH Bell;Curr Diabetes Rep,2001

4. Metformin–the gold standard in type 2 diabetes: what does the evidence tell us?;E Bosi;Diabetes Obes Metab,2009

5. The variant organic cation transporter 2 (OCT2)-T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin;Z Kashi;Diabetes Res Clin Pract,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Tropical Vegetable Oil Consumption on Lipid Profile and Glycaemic Control in Type 2 Diabetics;Trends in Medical Research;2024-07-13

2. Effects of metformin on the glucose regulation, lipid levels and gut microbiota in high-fat diet with streptozotocin induced type 2 diabetes mellitus rats;Endocrine;2024-05-23

3. Effects of metformin on the glucose regulation, lipid levels and gut microbiota in in high-fat diet with streptozotocin induced type 2 diabetes mellitus rats;2024-01-15

4. Lipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker Potential;Pharmaceuticals;2023-12-11

5. Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats;Journal of Lipid and Atherosclerosis;2023